GSK, MaRS Innovation Establish R&D Fund | June 6, 2011 Issue - Vol. 89 Issue 23 | Chemical & Engineering News
Volume 89 Issue 23 | p. 25 | Concentrates
Issue Date: June 6, 2011

GSK, MaRS Innovation Establish R&D Fund

Department: Business
Keywords: R&D, Innovation Fund, Canada

GlaxoSmithKline and MaRS Innovation, a Toronto-based nonprofit that commercializes intellectual property generated by local institutions, have established a new fund devoted to pulling research out of 16 Canadian academic institutions and hospitals and accelerating its translation into commercial products. The GSK-MaRS Innovation Fund will support research in drug development, diagnostics, and health care delivery technologies. The three-year partnership with GSK marks the second development fund launched by MaRS Innovation.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment